Activated Bacterial Therapeutic Platform

Optimizing Microbiome Delivery

ABT Platform Phase 1 Results

Advancing Healing Through Microbiome Therapeutics

Scioto Biosciences is a clinical stage biotech company dedicated to innovative research and discovery in the field of microbiome therapeutics. Our team has developed a proprietary Activated Bacterial Therapeutics (ABT) platform for delivering best-in-class, live therapeutic bacteria to the gut. Our solution is focused on the activation of beneficial bacteria that have the potential to advance healing for various diseases associated with the GI tract, Oncology and CNS indications.

About Us
Healing Through Microbiome Therapeutics